ストックスクリーナーアプリを入手
332.90
2.52%
8.221
Waters Corp (WAT) 最新ニュース
Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules – Company AnnouncementFT.com - Financial Times
Waters Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Big Picture: Will Waters Corporation outperform small cap indexes2026 Trends & Technical Pattern Recognition Alerts - baoquankhu1.vn
IAWAI growth assumptions questioned as waters company prepares strategy - Waikato Times
WAT SEC FilingsWaters 10-K, 10-Q, 8-K Forms - Stock Titan
WAT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Waters prices $3.5B senior notes offering - MSN
Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results - ADVFN
Waters Corporation (NYSE: WAT) Reports First Quarter 2021 Financial Results - ADVFN
Waters Corp Achieves Highest Daily Trading Volume of $270 Million, Rising 0.74% as Earnings Outlook Adjusts - Bitget
Waters Corporation (WAT) stock price, news, quote and history - Yahoo Finance Australia
WAT Earnings History & Surprises | EPS & Revenue Results | WATERS CORP (NYSE:WAT) - ChartMill
Waters (NYSE: WAT) highlights BD acquisition, 7% 2025 growth and performance-linked executive pay - Stock Titan
HARTFORD HEALTHCARE HLS FUND's Waters Corp(WAT) Holding History - GuruFocus
WAT Stock Price, Quote & Chart | WATERS CORP (NYSE:WAT) - ChartMill
Waters (WAT) Gains FDA Clearance for At-Home Cervical Cancer Scr - GuruFocus
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp Stock Surges on FDA Clearance: What Investors Need to Know Now - AD HOC NEWS
Waters Stock Shoots Higher As FDA Clears At-Home Cervical Cancer Screening Kit - Benzinga
Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay - Finviz
US FDA approves Waters' at‑home cervical cancer screening kit - Reuters
Waters (WAT) Gains FDA Approval for At-Home Cervical Cancer Scre - GuruFocus
FDA clears at-home HPV kit as 60% of cervical cancer cases hit unscreened people - Stock Titan
Waters Corp stock: What investors need to know in today's market - AD HOC NEWS
[Form 4] WATERS CORP /DE/ Insider Trading Activity - Stock Titan
Waters Corporation (NYSE:WAT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Evercore ISI upgrades Waters stock rating on achievable targets By Investing.com - Investing.com Australia
Evercore ISI upgrades Waters stock rating on achievable targets - Investing.com
Waters Corp : Evercore ISI Raises to Outperfo - Moomoo
Manufacturing Excellence Awards 2026: Waters Corp. - Worcester Business Journal
WAT Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Waters Corporation (WAT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Waters Corp (WAT) director gets deferred stock units grant - Stock Titan
Director Heather Knight granted deferred Waters (NYSE: WAT) stock units - Stock Titan
Waters Corp (MIL:1WAT) Bonds - GuruFocus
Parkman Healthcare Partners LLC's Waters Corp(WAT) Holding History - GuruFocus
Goldman Sachs Reinstates Buy Rating on Waters (WAT) Stock - GuruFocus
Waters Corp. stock rises Tuesday, still underperforms market - MarketWatch
Waters Corp (WAT) Expands After BD Diagnostic Solutions Acquisition - Insider Monkey
Waters Corp (WAT) Trading Down 3.79% on Mar 30 - GuruFocus
Waters Corp (LTS:0LTI) Bonds - GuruFocus
Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
Vanguard disaggregates holdings; Waters Corp shows 0% stake (WAT) - Stock Titan
Waters (MIC:WAT-RM) NonCurrent Deferred Revenue : ₽0.00 Mil (As of Dec. 2025) - GuruFocus
Waters Corp Stock: Analytical Instruments Leader Faces Growth Challenges Amid Sector Tailwinds - AD HOC NEWS
Waters Corp. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Waters (MIL:1WAT) NonCurrent Deferred Revenue : €0 Mil (As of Dec. 2025) - GuruFocus
Waters Corporation stock faces uncertainty amid Trump national security alert and market volatility - AD HOC NEWS
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - MSN
Waters Corp (WAT)'s Winning Formula: Financial Metrics and Compe - GuruFocus
Waters (WAT) Prices $3.5 Billion Senior Notes Offering - Insider Monkey
3.32%
大文字化:
|
ボリューム (24 時間):